Spanish Red Biotech Pipeline

MSD

Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Adjuvant Therapy with Pembrolizumab Vs. Placebo in Resected Stage II Melanoma.
Phase: 3Phase III in Spain, 2Phase II, 1Phase I